Abelardo López-Rivas

7PUBLICATIONS
6CO-AUTHORS
Molecular targetsLiquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 28, 2026
REDD1/DDIT4 counteracts endoplasmic reticulum stress-induced apoptosis by controlling the expression of death receptor TRAILR2/DR5 in cancer cells.

Rocío Mora-Molina, Younes El Yousfi, Cathrin Hagenlocher

|Jul 19, 2025
Activation of the integrated stress response and loss of cFLIPL under glutamine limitation induce IL-8 gene expression and secretion in glutamine-dependent tumor cells.

Rocío Mora-Molina, F Javier Fernández-Farrán, Abelardo López-Rivas

|Feb 05, 2025
Regulation of ER stress-induced apoptotic and inflammatory responses via YAP/TAZ-mediated control of the TRAIL-R2/DR5 signaling pathway.

Y El Yousfi, F J Fernández-Farrán, F J Oliver

|Oct 13, 2023
Role of the YAP/TAZ-TEAD Transcriptional Complex in the Metabolic Control of TRAIL Sensitivity by the Mevalonate Pathway in Cancer Cells.

Younes El Yousfi, Rocío Mora-Molina, Abelardo López-Rivas

|Oct 27, 2022
Limiting glutamine utilization activates a GCN2/TRAIL-R2/Caspase-8 apoptotic pathway in glutamine-addicted tumor cells.

Rosario Yerbes, Rocío Mora-Molina, F Javier Fernández-Farrán

|Aug 26, 2022
Restoring TRAILR2/DR5-Mediated Activation of Apoptosis upon Endoplasmic Reticulum Stress as a Therapeutic Strategy in Cancer.

Rocío Mora-Molina, Abelardo López-Rivas

Pageof 2

Frequent Collaborators

3 joint publications

Rosario Yerbes

3 joint publications

Rocío Mora-Molina

2 joint publications

Younes El Yousfi

2 joint publications

Markus Rehm